Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：101 Table Number：124
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Treatment of Internal Radionuclide Contamination market in this environment. In terms of revenue, this research report indicated that the global Treatment of Internal Radionuclide Contamination market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Treatment of Internal Radionuclide Contamination industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Hameln Pharma Plus Gmbh aims at producing XX Treatment of Internal Radionuclide Contamination in 2020, with XX % production to take place in global market, Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Treatment of Internal Radionuclide Contamination Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Treatment of Internal Radionuclide Contamination Market? Hameln Pharma Plus Gmbh Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG Mission Pharmacal Company Avondale Pharmaceuticals, Llc. Merck Annex Inc. Fleming & Company Recipharm AB ... Major Type of Treatment of Internal Radionuclide Contamination Covered in XYZResearch report: Potassium Iodide Prussian Blue Diethylenetriamine Pentaacetic Acid DMSA Others Application Segments Covered in XYZResearch Market Research and Academic Institutes Military and Energy Sectors Stockpile sectors Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Treatment of Internal Radionuclide Contamination Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Potassium Iodide -Product Introduction and Major Manufacturers 1.1.2 Prussian Blue -Product Introduction and Major Manufacturers 1.1.3 Diethylenetriamine Pentaacetic Acid -Product Introduction and Major Manufacturers 1.1.4 DMSA -Product Introduction and Major Manufacturers 1.1.5 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Treatment of Internal Radionuclide Contamination Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Treatment of Internal Radionuclide Contamination Market 3.1.1 Top Companies leading Treatment of Internal Radionuclide Contamination Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Treatment of Internal Radionuclide Contamination Market 3.2.1 Top Companies leading Treatment of Internal Radionuclide Contamination Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Treatment of Internal Radionuclide Contamination Market 3.3.1 Top Companies leading Treatment of Internal Radionuclide Contamination Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Treatment of Internal Radionuclide Contamination Market 3.4.1 Top Companies leading Treatment of Internal Radionuclide Contamination Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Treatment of Internal Radionuclide Contamination Market 3.5.1 Top Companies leading Treatment of Internal Radionuclide Contamination Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Treatment of Internal Radionuclide Contamination Market 3.6.1 Top Companies leading Treatment of Internal Radionuclide Contamination Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Treatment of Internal Radionuclide Contamination Market 3.7.1 Top Companies leading Treatment of Internal Radionuclide Contamination Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Treatment of Internal Radionuclide Contamination Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Treatment of Internal Radionuclide Contamination Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Treatment of Internal Radionuclide Contamination Sales and Growth Rate (2021-2026) 5.2 Global Treatment of Internal Radionuclide Contamination Sales Value and Growth Rate (2021-2026) 6 Treatment of Internal Radionuclide Contamination Competitive Analysis 6.1 Hameln Pharma Plus Gmbh 6.1.1 Hameln Pharma Plus Gmbh Company Profiles 6.1.2 Hameln Pharma Plus Gmbh Product Introduction 6.1.3 Hameln Pharma Plus Gmbh Treatment of Internal Radionuclide Contamination Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG 6.2.1 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG Company Profiles 6.2.2 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG Product Introduction 6.2.3 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG Treatment of Internal Radionuclide Contamination Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Mission Pharmacal Company 6.3.1 Mission Pharmacal Company Company Profiles 6.3.2 Mission Pharmacal Company Product Introduction 6.3.3 Mission Pharmacal Company Treatment of Internal Radionuclide Contamination Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Avondale Pharmaceuticals, Llc. 6.4.1 Avondale Pharmaceuticals, Llc. Company Profiles 6.4.2 Avondale Pharmaceuticals, Llc. Product Introduction 6.4.3 Avondale Pharmaceuticals, Llc. Treatment of Internal Radionuclide Contamination Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Merck 6.5.1 Merck Company Profiles 6.5.2 Merck Product Introduction 6.5.3 Merck Treatment of Internal Radionuclide Contamination Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Annex Inc. 6.6.1 Annex Inc. Company Profiles 6.6.2 Annex Inc. Product Introduction 6.6.3 Annex Inc. Treatment of Internal Radionuclide Contamination Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Fleming & Company 6.7.1 Fleming & Company Company Profiles 6.7.2 Fleming & Company Product Introduction 6.7.3 Fleming & Company Treatment of Internal Radionuclide Contamination Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 Recipharm AB 6.8.1 Recipharm AB Company Profiles 6.8.2 Recipharm AB Product Introduction 6.8.3 Recipharm AB Treatment of Internal Radionuclide Contamination Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Treatment of Internal Radionuclide Contamination Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Treatment of Internal Radionuclide Contamination Sales (K Unit) by Type (2015-2026) Figure Global Treatment of Internal Radionuclide Contamination Sales (K Unit) and Growth Rate (2015-2026) Figure Global Treatment of Internal Radionuclide Contamination Sales Market Share (%) by Type (2019 -2020) Table Global Treatment of Internal Radionuclide Contamination Sales Value (Million USD) by Type (2015-2026) Figure Global Treatment of Internal Radionuclide Contamination Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Treatment of Internal Radionuclide Contamination Sales Value Market Share (%) by Type (2019-2020) Table Global Treatment of Internal Radionuclide Contamination Sales (K Unit) by Application (2015-2026) Table China Treatment of Internal Radionuclide Contamination Sales (K Unit) of Major Company (2015-2020) Table China Treatment of Internal Radionuclide Contamination Sales Market Share of Major Company (2015-2020) Table China Treatment of Internal Radionuclide Contamination Sales Value (Million USD) of Major Company (2015-2020) Figure China Treatment of Internal Radionuclide Contamination Sales Value (Million USD) and Growth Rate (2015-2020) Table China Treatment of Internal Radionuclide Contamination Sales Value Share of Major Company (2015-2020) Table China Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) Table China Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Figure China Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Table EU Treatment of Internal Radionuclide Contamination Sales (K Unit) of Major Company (2015-2020) Table EU Treatment of Internal Radionuclide Contamination Sales Market Share of Major Company (2015-2020) Table EU Treatment of Internal Radionuclide Contamination Sales Value (Million USD) of Major Company (2015-2020) Figure EU Treatment of Internal Radionuclide Contamination Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Treatment of Internal Radionuclide Contamination Sales Value Share of Major Company (2015-2020) Table EU Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) Table EU Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Figure EU Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Table USA Treatment of Internal Radionuclide Contamination Sales (K Unit) of Major Company (2015-2020) Table USA Treatment of Internal Radionuclide Contamination Sales Market Share of Major Company (2015-2020) Table USA Treatment of Internal Radionuclide Contamination Sales Value (Million USD) of Major Company (2015-2020) Figure USA Treatment of Internal Radionuclide Contamination Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Treatment of Internal Radionuclide Contamination Sales Value Share of Major Company (2015-2020) Table USA Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) Table USA Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Figure USA Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Table Japan Treatment of Internal Radionuclide Contamination Sales (K Unit) of Major Company (2015-2020) Table Japan Treatment of Internal Radionuclide Contamination Sales Market Share of Major Company (2015-2020) Table Japan Treatment of Internal Radionuclide Contamination Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Treatment of Internal Radionuclide Contamination Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Treatment of Internal Radionuclide Contamination Sales Value Share of Major Company (2015-2020) Table Japan Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) Table Japan Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Figure Japan Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Table India Treatment of Internal Radionuclide Contamination Sales (K Unit) of Major Company (2015-2020) Table India Treatment of Internal Radionuclide Contamination Sales Market Share of Major Company (2015-2020) Table India Treatment of Internal Radionuclide Contamination Sales Value (Million USD) of Major Company (2015-2020) Figure India Treatment of Internal Radionuclide Contamination Sales Value (Million USD) and Growth Rate (2015-2020) Table India Treatment of Internal Radionuclide Contamination Sales Value Share of Major Company (2015-2020) Table India Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) Table India Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Figure India Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Table Southeast Asia Treatment of Internal Radionuclide Contamination Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Treatment of Internal Radionuclide Contamination Sales Market Share of Major Company (2015-2020) Table Southeast Asia Treatment of Internal Radionuclide Contamination Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Treatment of Internal Radionuclide Contamination Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Treatment of Internal Radionuclide Contamination Sales Value Share of Major Company (2015-2020) Table Southeast Asia Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Figure Southeast Asia Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Table South America Treatment of Internal Radionuclide Contamination Sales (K Unit) of Major Company (2015-2020) Table South America Treatment of Internal Radionuclide Contamination Sales Market Share of Major Company (2015-2020) Table South America Treatment of Internal Radionuclide Contamination Sales Value (Million USD) of Major Company (2015-2020) Figure South America Treatment of Internal Radionuclide Contamination Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Treatment of Internal Radionuclide Contamination Sales Value Share of Major Company (2015-2020) Table South America Treatment of Internal Radionuclide Contamination Price (USD/Unit), by Type (2019-2020) Table South America Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Figure South America Treatment of Internal Radionuclide Contamination Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Treatment of Internal Radionuclide Contamination Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Treatment of Internal Radionuclide Contamination Figure Cost Structure of Treatment of Internal Radionuclide Contamination in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Treatment of Internal Radionuclide Contamination Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Treatment of Internal Radionuclide Contamination Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table Hameln Pharma Plus Gmbh Profiles Table Hameln Pharma Plus Gmbh Treatment of Internal Radionuclide Contamination Product Introduction Table Hameln Pharma Plus Gmbh Treatment of Internal Radionuclide Contamination Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Hameln Pharma Plus Gmbh SWOT Analysis Table Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG Profiles Table Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG Treatment of Internal Radionuclide Contamination Product Introduction Table Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG Treatment of Internal Radionuclide Contamination Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG SWOT Analysis Table Mission Pharmacal Company Profiles Table Mission Pharmacal Company Treatment of Internal Radionuclide Contamination Product Introduction Table Mission Pharmacal Company Treatment of Internal Radionuclide Contamination Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Mission Pharmacal Company SWOT Analysis Table Avondale Pharmaceuticals, Llc. Profiles Table Avondale Pharmaceuticals, Llc. Treatment of Internal Radionuclide Contamination Product Introduction Table Avondale Pharmaceuticals, Llc. Treatment of Internal Radionuclide Contamination Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Avondale Pharmaceuticals, Llc. SWOT Analysis Table Merck Profiles Table Merck Treatment of Internal Radionuclide Contamination Product Introduction Table Merck Treatment of Internal Radionuclide Contamination Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Merck SWOT Analysis Table Annex Inc. Profiles Table Annex Inc. Treatment of Internal Radionuclide Contamination Product Introduction Table Annex Inc. Treatment of Internal Radionuclide Contamination Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Annex Inc. SWOT Analysis Table Fleming & Company Profiles Table Fleming & Company Treatment of Internal Radionuclide Contamination Product Introduction Table Fleming & Company Treatment of Internal Radionuclide Contamination Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Fleming & Company SWOT Analysis Table Recipharm AB Profiles Table Recipharm AB Treatment of Internal Radionuclide Contamination Product Introduction Table Recipharm AB Treatment of Internal Radionuclide Contamination Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
